252 related articles for article (PubMed ID: 24859338)
1. Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma.
Wang X; Bledsoe KL; Graham RP; Asmann YW; Viswanatha DS; Lewis JE; Lewis JT; Chou MM; Yaszemski MJ; Jen J; Westendorf JJ; Oliveira AM
Nat Genet; 2014 Jul; 46(7):666-8. PubMed ID: 24859338
[TBL] [Abstract][Full Text] [Related]
2. Alternate PAX3-FOXO1 oncogenic fusion in biphenotypic sinonasal sarcoma.
Wong WJ; Lauria A; Hornick JL; Xiao S; Fletcher JA; Marino-Enriquez A
Genes Chromosomes Cancer; 2016 Jan; 55(1):25-9. PubMed ID: 26355893
[TBL] [Abstract][Full Text] [Related]
3. Fusion gene profile of biphenotypic sinonasal sarcoma: an analysis of 44 cases.
Fritchie KJ; Jin L; Wang X; Graham RP; Torbenson MS; Lewis JE; Rivera M; Garcia JJ; Schembri-Wismayer DJ; Westendorf JJ; Chou MM; Dong J; Oliveira AM
Histopathology; 2016 Dec; 69(6):930-936. PubMed ID: 27454570
[TBL] [Abstract][Full Text] [Related]
4. Biphenotypic sinonasal sarcoma: demographics, clinicopathological characteristics, molecular features, and prognosis of a recently described entity.
Andreasen S; Bishop JA; Hellquist H; Hunt J; Kiss K; Rinaldo A; Skálová A; Willems SM; Williams M; Ferlito A
Virchows Arch; 2018 Nov; 473(5):615-626. PubMed ID: 30109475
[TBL] [Abstract][Full Text] [Related]
5. Novel PAX3-NCOA1 Fusions in Biphenotypic Sinonasal Sarcoma With Focal Rhabdomyoblastic Differentiation.
Huang SC; Ghossein RA; Bishop JA; Zhang L; Chen TC; Huang HY; Antonescu CR
Am J Surg Pathol; 2016 Jan; 40(1):51-9. PubMed ID: 26371783
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and Molecular Features of a Series of 41 Biphenotypic Sinonasal Sarcomas Expanding Their Molecular Spectrum.
Le Loarer F; Laffont S; Lesluyes T; Tirode F; Antonescu C; Baglin AC; Delespaul L; Soubeyran I; Hostein I; Pérot G; Chibon F; Baud J; Le Guellec S; Karanian M; Costes-Martineau V; Castain C; Eimer S; Le Bail B; Wassef M; Coindre JM
Am J Surg Pathol; 2019 Jun; 43(6):747-754. PubMed ID: 30829729
[TBL] [Abstract][Full Text] [Related]
7. Imprint cytology of biphenotypic sinonasal sarcoma of the paranasal sinus: A case report.
Sugita S; Kubo T; Aoyama T; Moriya J; Okuni T; Wanibuchi M; Yamashita K; Onodera M; Tsujiwaki M; Segawa K; Sugawara T; Hasegawa T
Diagn Cytopathol; 2019 May; 47(5):507-511. PubMed ID: 30592181
[TBL] [Abstract][Full Text] [Related]
8. RREB1-MKL2 fusion in biphenotypic "oropharyngeal" sarcoma: New entity or part of the spectrum of biphenotypic sinonasal sarcomas?
Siegfried A; Romary C; Escudié F; Nicaise Y; Grand D; Rochaix P; Barres B; Vergez S; Chevreau C; Coindre JM; Uro-Coste E; Le Guellec S
Genes Chromosomes Cancer; 2018 Apr; 57(4):203-210. PubMed ID: 29266774
[TBL] [Abstract][Full Text] [Related]
9. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3.
Fredericks WJ; Galili N; Mukhopadhyay S; Rovera G; Bennicelli J; Barr FG; Rauscher FJ
Mol Cell Biol; 1995 Mar; 15(3):1522-35. PubMed ID: 7862145
[TBL] [Abstract][Full Text] [Related]
10. RREB1-MKL2 fusion in a spindle cell sinonasal sarcoma: biphenotypic sinonasal sarcoma or ectomesenchymal chondromyxoid tumor in an unusual site?
Mechtersheimer G; Andrulis M; Delank KW; Volckmar AL; Zhang L; von Winterfeld M; Stenzinger A; R Antonescu C
Genes Chromosomes Cancer; 2021 Aug; 60(8):565-570. PubMed ID: 33715240
[TBL] [Abstract][Full Text] [Related]
11. Biphenotypic Sinonasal Sarcoma with a Novel PAX3::FOXO6 Fusion: A Case Report and Review of the Literature.
Nichols MM; Alruwaii F; Chaaban M; Cheng YW; Griffith CC
Head Neck Pathol; 2023 Mar; 17(1):259-264. PubMed ID: 36169791
[TBL] [Abstract][Full Text] [Related]
12. Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1.
Wachtel M; Dettling M; Koscielniak E; Stegmaier S; Treuner J; Simon-Klingenstein K; Bühlmann P; Niggli FK; Schäfer BW
Cancer Res; 2004 Aug; 64(16):5539-45. PubMed ID: 15313887
[TBL] [Abstract][Full Text] [Related]
13. Biphenotypic sinonasal sarcoma with PAX3/FOXO1 fusion.
Tosun I; Karabulut MH; Yilmaz I; Cırık AA; Sahin O
Pol J Pathol; 2023; 74(4):282-285. PubMed ID: 38477090
[TBL] [Abstract][Full Text] [Related]
14. Biphenotypic Sinonasal Sarcoma with a Novel PAX7::PPARGC1 Fusion: Expanding the Spectrum of Gene Fusions Beyond the PAX3 Gene.
Bhele S; Chrisinger JSA; Farrell NF; Van Tine BA; Raptis CA; Chernock RD
Head Neck Pathol; 2023 Sep; 17(3):826-831. PubMed ID: 37378830
[TBL] [Abstract][Full Text] [Related]
15. Biphenotypic sinonasal sarcoma with PAX3::MAML3 fusion transforming into high-grade rhabdomyosarcoma: report of an emerging rare phenomenon.
Meyer A; Klubíčková N; Mosaieby E; Grossmann P; Kalmykova A; Koshyk O; Michal M
Virchows Arch; 2023 Apr; 482(4):777-782. PubMed ID: 36719455
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional studies of FKHR-PAX3, a reciprocal fusion gene of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcoma.
Hu Q; Yuan Y; Wang C
PLoS One; 2013; 8(6):e68065. PubMed ID: 23799156
[TBL] [Abstract][Full Text] [Related]
17. Pax3 inhibits myogenic differentiation of cultured myoblast cells.
Epstein JA; Lam P; Jepeal L; Maas RL; Shapiro DN
J Biol Chem; 1995 May; 270(20):11719-22. PubMed ID: 7744814
[TBL] [Abstract][Full Text] [Related]
18. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.
Sublett JE; Jeon IS; Shapiro DN
Oncogene; 1995 Aug; 11(3):545-52. PubMed ID: 7630639
[TBL] [Abstract][Full Text] [Related]
19. Expression of PAX3 Distinguishes Biphenotypic Sinonasal Sarcoma From Histologic Mimics.
Jo VY; Mariño-Enríquez A; Fletcher CDM; Hornick JL
Am J Surg Pathol; 2018 Oct; 42(10):1275-1285. PubMed ID: 29863547
[TBL] [Abstract][Full Text] [Related]
20. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma.
Shapiro DN; Sublett JE; Li B; Downing JR; Naeve CW
Cancer Res; 1993 Nov; 53(21):5108-12. PubMed ID: 8221646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
